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Abstract
Background: Human adenoviruses (HAdV) play a significant role in pediatric respiratory tract infections. To date, over
60 types of HAdV have been identified. Here, HAdV types are characterized in children in the Beijing area with acute
lower respiratory tract infections (ALRTIs) and the clinical features and laboratory findings of hospitalized HAdV-infected
cases are described.
Methods: Respiratory specimens were collected from pediatric patients with ALRTIs in the emergency
department or from those admitted to Beijing Children’s Hospital between March 2007 and December 2012.
Infections with common respiratory viruses were determined by PCR or RT-PCR. HAdV positive samples were
further typed by PCR and sequencing.
Results: Among 3356 patients with ALRTIs, 194 (5.8 %) were found to have HAdV infection. HAdV infection was
primarily confined to children (88.35 %) less than 5 years of age. A total of 11 different types of HAdV were detected
throughout the study period, with HAdV-B7 (49.0 %) and HAdV-B3 (26.3 %) as the most prevalent types, followed by
HAdV-C2 (7.7 %) and HAdVC1 (4.6 %). Newly emerging and re-emergent types or variants, HAdV-B55 (n = 5), HAdV-C57
(n = 3), and HAdV-B14p1 (n = 1), were identified. Results also included the reported first case of co-infection with
HAdV-C2 and HAdV-C57. Clinical entities of patients with single HAdV infection (n = 49) were similar to those with
mixed HAdV/respiratory syncytial virus (RSV) infections (n = 41). Patients with HAdV-B7 infection had longer duration of
fever and higher serum levels of muscle enzymes than HAdV-B3-infected patients.
Conclusions: During the study period, HAdV-B7 and HAdV-B3 were the predominant types identified in pediatric
ALRTIs. HAdV-B7 infection tends to have more severe clinical consequences. The presence of newly emerging types or
variants and co-infection with different types of HAdV highlights the need for constant and close surveillance of HAdV
infection.
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Background
Acute lower respiratory tract infections (ALRTIs) are the
leading cause of pediatric morbidity and mortality world-
wide, particularly in developing countries. In infants and
young children, ALRTIs are most frequently caused by re-
spiratory viruses. One such virus, human adenovirus
(HAdV), plays a significant role in pediatric respiratory
tract infections, accounting for 2–5 % of the overall re-
spiratory illnesses and 4–10 % of the pneumonias [1, 2].
Although most cases are mild and indistinguishable from
other viral causes, ALRTIs caused by HAdV can be severe,
or even fatal, and are associated with the highest risk of
long term respiratory sequelae [3]. Thus, HAdV-
associated ALRTIs are of particular interest to both clini-
cians and researchers.
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HAdV are responsible for a wide spectrum of clinical
diseases, including respiratory illness (both upper and
lower respiratory tract), pharyngoconjunctival fever, con-
junctivitis, cystitis, gastroenteritis, and neurologic and
venereal disease [4]. HAdV were first isolated in 1953 as
respiratory pathogens [5, 6]. To date, over 60 types of
HAdV have been identified and classified into seven spe-
cies (A to G) [7–14]. Cases of severe infection, outbreaks
in closed populations, and even epidemic outbreaks have
been associated with the newly emerging or re-emergent
types or variants [15–17].
Interestingly, different types of HAdV display various
tissue tropisms that correlate with different clinical man-
ifestations of infection. HAdV infections of the respira-
tory tract are predominantly caused by HAdV-B
(including subspecies B1 and B2), HAdV-C, or HAdV-E.
The predominant types vary among different countries
and regions and they change over time because trans-
mission of novel strains between countries or across
continents may occur [18].
Type identification is critical to epidemiological sur-
veillance, detection of new strains, and understanding of
HAdV pathogenesis. However, because most clinical
laboratories do not type the isolates, there is little pub-
lished information about epidemiologic and clinical
features of HAdV infections by type in children with
ALRTIs. To identify HAdV types and species in children
with ALRTIs in Beijing area and to characterize clinical
features and laboratory findings of hospitalized HAdV-
infected cases, respiratory specimens were collected from
hospital-admitted pediatric patients with ALRTIs and
typed HAdV positive samples using PCR and sequencing.
Methods
Ethics statement
The study protocol was approved by the Ethical Review
Committee of Beijing Children’s Hospital. Individual
written informed consent was obtained from the parents
or guardians of all participants.
Patients and clinical specimens
From March 2007 to December 2012, pediatric patients
with ALRTIs who presented in emergency department
or were admitted to respiratory department or intensive
care unit, Beijing Children’s Hospital, were recruited for
the study. The study site hospital is a tertiary compre-
hensive pediatric hospital with over 900 beds and more
than twenty clinical departments. ALRTIs were defined
as the presence of signs and symptoms of respiratory
tract infection (i.e., fever, coughing, rhinorrhea, oropha-
ryngeal hyperemia, swelling of tonsils), and lower
respiratory signs (tachypnea, dyspnea, retractions, or
wheezing/rales upon auscultation). The patients were
diagnosed with bronchitis, bronchiolitis or pneumonia.
Chest X-rays were taken for all patients and the criteria
for diagnosing pneumonia are the presence of lung infil-
trates indicated by chest radiography. Nasopharyngeal
aspirate or throat swab specimens were collected in
virus transport media from each patient. No repeated
samples were collected from any patient. All samples
were stored at −80 °C prior to use.
Preparation of nucleic acids
Total nucleic acids (DNA and RNA) were extracted
from 200 μl nasopharyngeal aspirate or throat swab
specimens using the NucliSens easyMAG™ automated
extraction system (bioMérieux, Marcy l’Etoile, France)
according to the manufacturer’s instructions and eluted
in 60 μl elution buffer.
Detection of respiratory viruses
The presence of common respiratory viral agents, in-
cluding parainfluenza virus (PIV) type 1–4, influenza
virus (IFV), respiratory syncytial virus (RSV), human
rhinovirus (HRV), enterovirus (EV), human coronavirus
(HCoV 229E, NL63, HKU1, and OC43), human metap-
neumovirus (HMPV), human bocavirus (HBoV), and
HAdV was determined by multiplex RT-PCR, single RT-
PCR, or PCR assays as previously described [19, 20].
Blank virus transport media here served as a negative
control for nucleic acid extraction and PCR.
Molecular typing and phylogenetic analysis of HAdV
HAdV positive samples were further amplified using a
nested PCR procedure that targeted hyper variable
regions 1–6 of the hexon gene as described by Lu
and Erdman [21]. Expected amplicons ranged from
688 bp to 821 bp (secondary amplification) in length.
Sequencing was performed in both directions using
the amplification primers.
Sequences were proof read and assembled using
SeqMan software v7.1.0 (DNASTAR Inc., WI, U.S.).
For assignment of molecular identity and identifica-
tion of the closest match, sequence alignment was
performed using the Basic Local Alignment Search
Tool (BLAST) against NCBI GenBank database
(http://www.ncbi.nlm.nih.gov).
Clinical data collection
Clinical data were retrospectively recorded by careful
analysis of patient medical files in Beijing Children’s
Hospital, using a predefined Microsoft Excel spread-
sheet. Patients’ demographic, clinical, and radiologic
findings were collected.
Statistical analyses
Continuous variables were summarized as means ± stand-
ard deviations (SD) or medians. For categorical variables,
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percentages of patients in each category were calculated.
Differences between groups were assessed using Pearson’s
Chi square test or Fisher’s exact test for categorical vari-
ables and the one way ANOVA, Independent-Samples T
test, Mann–Whitney U test, and Kruskal-Wallis test for
continuous variables. All analyses were performed using
SPSS software, version 19.0 (IBM Corporation, NY, U.S.).
All tests were calculated in a two-tailed manner and a P
value of <0.05 was considered statistically significant.
Results
Frequency of HAdV in children with ALRTIs
From March 2007 through December 2012, a total of
3356 patients with ALRTIs (2766 with pneumonia, 309
with bronchitis and 281 with bronchiolitis) were enrolled
in this study. The mean age of study participants was
3.87 ± 4.03 years (median 1 year; age range, 0.5 month to
17 years and 17 months). There were 2085 male partici-
pants with a male-to-female ratio of 1.64:1.
At least one respiratory virus was detected in nasopha-
ryngeal aspirate or throat swab specimens of 2322 (69.2
%) enrolled participants. RSV (33.4 %) was the most
commonly detected viral pathogen, followed by HRV
(26.6 %) and PIV (13.6 %). One hundred and ninety-four
patients (5.8 %, 194/3356) were found to have HAdV
infection, representing 8.7 % (194/2232) of patients with
positive respiratory samples. Male paticipants were more
likely to be infected with HAdV (135 boys and 59 girls,
male to female ratio = 2.3:1). The mean age of infection
was 2.13 ± 2.68 years (median, 1 year; age range, 1 month
to 15 years). Most of HAdV-infected cases (88.35 %)
were under 5 years of age and the highest percentage of
HAdV infections (42.47 %) occurred in infants (age
group 0– < 1 year), followed by the age group 1– <
2 years (27.84 %).
Additionally, one or more other respiratory viruses
were detected in 69.6 % (n = 135) of 194 HAdV-infected
participants. Dual viral infection was identified in 75
cases, triple infection in 45 cases, quadruple in 13
and quintuple in 2. RSV (n = 56) was the most fre-
quently co-detected virus, followed by HRV (n = 53)
and PIV (n = 42). HBoV (n = 24), HCoV (n = 15), IFV
(n = 8), EV (n = 6), and HMPV (n = 5) were also found
to be co-infected with HAdV.
Typing of HAdV
One hundred and ninety-four HAdV-positive specimens
were all successfully typed by hexon gene amplifying and
sequencing. Throughout the study period, four species (A,
B, C, E) of HAdV, including 11 different types were identi-
fied. Additionally, HAdV-B7 (n = 95; 49.0 %) and HAdV-
B3 (n = 51; 26.3 %), which belong to species B, were the
most prevalent HAdV types, accounting for 75.3 % of all
HAdV-associated infections. HAdV-C2 (7.7 %), HAdV-C1
(4.6 %), HAdV-C5 (3.6 %), HAdV-B55 (2.6 %), HAdV-C6
(1.5 %), HAdV-C57 (1.5 %), HAdV-A31 (1.0 %), HAdV-
B14 (0.5 %), and HAdV-E4 (0.5 %) were also detected.
Interestingly, sequencing results from one specimen
showed superimposed peaks in the chromatograms. To
confirm the possibility of multiple HAdV strains in that
sample, PCR products were cloned and sequenced
further. Distinct hexon genes of different types (HAdV-
C2 and HAdV-C57) were verified.
Temporal distribution of HAdV
HAdV detection rate varied through the years, ranging
from 2.55 % in 2007 to 9.15 % in 2010 (Fig. 1). Addition-
ally, Although HAdV was detected throughout the year,
cases commonly peaked in winter and spring season
(Fig. 2). Furthermore, different types of HAdV did not
remain constant across the whole study period (Fig. 2).
Specifically, HAdV-C1, −C2, −B3, and -B7 were detected
throughout the study; HAdV-C5 in all years except
2007; HAdV-C6 and HAdV-C57 in years 2008, 2009,
Fig. 1 Samples collected and proportion of samples with HAdV identified in each year, 2007–2012
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and 2012; HAdV-B55 in 2008, 2011, and 2012; and
HAdV-E4, HAdV-A31, and HAdV-B14 in years 2007,
2009, and 2010, respectively.
Clinical features of HAdV infections
Among the 194 HAdV-positive cases, 150 hospitalized
cases were included in the clinical analysis, and 44 cases
from the emergency department for which the details of
the medical records were not available were excluded.
Pneumonia (n = 142, 94.7 %) was the most common
clinical diagnosis, followed by bronchitis (n = 7) and bron-
chiolitis (n = 1). Additionally, almost all hospitalized
HAdV-infected patients presented with fever (144/150,
96.0%) and coughing (149/150, 99.3 %) (Table 1). The
mean peak body temperature was 39.53 ± 0.67 °C (n = 144,
range 37.3 − 41.4 °C) and febrile seizures were noted in
two febrile patients. In addition to respiratory symptoms,
diarrhea, vomiting, skin rash, and conjunctivitis were
noted in 21.3 %, 9.3 %, 10.0 % and 4.7 % of the pa-
tients respectively. Twenty-two patients (14.7 %) had
underlying diseases, which included congenital heart
disease (8 patients), airway anomaly (malacia, stenosis,
11 patients), bronchopulmonary dysplasia (1 patient),
asthma (2 patients), or primary immunodeficiency (1 pa-
tient). Seventeen patients (11.3 %) required admission to
the intensive care unit and 38 patients (11.3 %) received
mechanical ventilation including both noninvasive (n =
31) and invasive (n = 7) modes. Analysis revealed that the
mean value of white blood cell (WBC) count was 10.09 ±
4.61 × 109/L (Table 2). Leukocytosis (WBC > 12.0 × 109/L)
was observed in 37 (24.7 %) patients. Eighty-one patients
(54.0 %) had elevated serum C-reaction protein (CRP).
Given RSV was the virus most frequently co-detected
with HAdV, differences among patients with single
HAdV infection (n = 49) and those with HAdV/RSV co-
infections, including both dual infections (n = 18) and
multiple infections (HAdV/RSV with one or more other
respiratory viruses, n = 23), were assessed (Table 1). The
mean age of patients with multiple infections (1.20 ±
0.81) and dual infections (1.53 ± 2.41) was significantly
younger than those with single HAdV infection (3.68 ±
3.64) (P = 0.001). However clinical characteristics and
laboratory findings showed no significant differences
among different groups.
Because HAdV-B7 and HAdV-B3 were the most pre-
dominant type among patients with HAdV infection, the
clinical entities of patients with single HAdV-B7 infec-
tion (n = 30) and those with single HAdV-B3 infection
(n = 15) were also compared to exclude the possible
effect of other respiratory virus infection (Table 2).
Patients with single HAdV-B7 infection showed longer
duration of fever (22.07 ± 21.52 vs 9.73 ± 7.31, P = 0.038)
than patients with HAdV-B3 alone. Immunoglobulin
was more frequently used in single HAdV-B7 infected
patients than in single HAdV-B3 group (P = 0.038). Pa-
tients with HAdV-B7 alone also tend to require longer
hospital stay (18.50 ± 12.87 vs 12.33 ± 4.95, P = 0.082)
than those with single HAdV-B3 infection, although
no significant difference was found. Biochemical tests
demonstrated aspartate aminotransferase (AST), ala-
nine aminotransferase (ALT), lactate dehydrogenase
(LDH) and hydroxybutyrate dehydrogenase (HBDH)
levels were significantly higher in the single HAdV-B7
infected group.
Two patients died in-hospital. Both of them required
ICU admission and died of multiple organ failure. One
was a 17 month-old boy with multiple underlying condi-
tions of complex congenital heart disease and tracheo-
bronchial malformation. The other was a previously
healthy 18 month-old boy. Analysis indicated that both
fatal patients were infected with HAdV-B7 but no other
respiratory viruses.
Discussion
HAdV is a significant causative agent of respiratory tract
illnesses in both children and adults. Here, the molecular
Fig. 2 Seasonal distribution of HAdV infection in children with ALRTIs from 2007 to 2012. Detection numbers of different types of HAdV are shown in
each month
Liu et al. BMC Infectious Diseases  (2015) 15:408 Page 4 of 9
epidemiology and clinical features of HAdV associated
pediatric ALRTIs in Beijing Children’s Hospital from
March 2007 to December 2012 were described. Results
showed that the HAdV infection rate in the current study
population was 5.8 %, which was consistent with previous
reports from China and other countries [22–24]. Results
showed that most patients with HAdV infection were
younger than 5 years (88.35 %), which is similar to
numbers reported in previous studies [1, 22, 23, 25–27].
This may because the immune systems of young children
are not well developed, which leaves them prone to more
severe HAdV disease. This may also suggest that school-
age children are exposed to the most common endemic
types of HAdV early in life, thereby establishing a protect-
ive immunity resulting only in mild clinical symptoms,
such that upper respiratory tract infection does not
Table 1 Clinical manifestations and laboratory findings of HAdV infections in 150 hospitalized children with ALRTIs
Group
Variables All cases HAdV HAdV/RSV HAdV/RSV
Single infection Dual infections Multiple infections
(n = 150) (n = 49) (n = 18) (n = 23)
Age (years)a 2.37 ± 2.89 3.68 ± 3.64 1.53 ± 2.41 1.20 ± 0.81
Male (%) 105 (70 %) 32 (65.3 %) 12 (66.7 %) 17 (73.9 %)
Symptoms and signs
Fever 144 (96.0 %) 48 (98.0 %) 17 (94.4 %) 23 (100 %)
T max (°C) 39.53 ± 0.68 39.73 ± 0.66 39.48 ± 0.53 39.62 ± 0.73
Duration of fever (days) 15.31 ± 13.35 18.06 ± 18.85 14.18 ± 5.86 15.17 ± 7.25
Cough 149 (99.3 %) 49 (100 %) 18 (100 %) 23 (100 %)
Rhinorrhea 24 (16.0 %) 8 (16.3 %) 2 (11.1 %) 4 (17.4 %)
Wheezing 90 (60.0 %) 25 (51.0 %) 14 (77.8 %) 17 (73.9 %)
Swelling of tonsils 44 (29.3 %) 18 (36.7 %) 2 (11.1 %) 3 (13.0 %)
Rash 15 (10.0 %) 5 (10.2 %) 7 (12.3 %) 3 (6.8 %)
Vomitting 14 (9.3 %) 5 (10.2 %) 1 (5.6 %) 4 (17.4 %)
Diarrhea 32 (21.3 %) 11 (22.4 %) 3 (16.7 %) 7 (30.4 %)
Conjunctivitis 7 (4.7 %) 2 (4.1 %) 1 (5.6 %) 0 (0 %)
Dyspnea 61 (40.7 %) 18 (36.7 %) 8 (44.4 %) 12 (52.2 %)
ICU admission 17 (11.3 %) 7 (14.3 %) 2 (11.1 %) 5 (21.7 %)
Any underlying diseases 22 (14.7 %) 10 (20.4 %) 2 (11.1 %) 2 (8.7 %)
Treatment
Mechanical ventilation 38 (25.3 %) 13 (26.5 %) 4 (22.2 %) 8 (34.8 %)
Coticosteriods 122 (81.3 %) 40 (81.6 %) 13 (72.2 %) 22 (95.7 %)
Inhaled Intravenous 74 (49.3 %) 22 (44.9 %) 8 (44.4 %) 14 (60.9 %)
Immunoglobulin 34 (22.7 %) 8 (16.3 %) 1 (5.6 %) 6 (26.1 %)
Length of hospital stay (days) 18.32 ± 11.31 16.19 ± 11.01 20.17 ± 10.22 20.52 ± 10.44
Laboratory findings
WBC (×109/L) 10.09 ± 4.61 9.34 ± 4.85 10.50 ± 3.79 9.86 ± 4.26
CRP (mg/L) 31.64 ± 35.93 36.01 ± 39.67 36.78 ± 30.25 32.42 ± 43.52
AST, median (IQR) (U/L) 33 (45–71.5) 45 (34–81.8) 38.5 (33–56.3) 57 (33–83)
ALT, median (IQR) (U/L) 21 (16–36) 18.1 (15–33) 21 (18–36.5) 22 (19–46)
LDH, median (IQR) (U/L) 360 (262.5-668.5) 369.5 (285.7-899.5) 326.5 (260–584.5) 439 (288–747)
CK, median (IQR) (U/L) 83 (45–192) 87.5 (46.8-264) 84 (42.5-221.8) 88 (38–137)
HBDH, median (IQR) (U/L) 274 (200.5-508.5) 275 (203.3-562.3) 258 (203–447.9) 355 (221.5–524)
ICU intensive care unit, WBC white blood cell, CRP C-reaction protein, AST aspartate aminotransferase, ALT alanine aminotransferase, LDH, lactate dehydrogenase,
CK creatinine kinase, HBDH hydroxybutyrate dehydrogenase, IQR interquartile range
aone way ANOVA: single infection vs dual infections vs multiple infections, p = 0.001
Liu et al. BMC Infectious Diseases  (2015) 15:408 Page 5 of 9
Table 2 Clinical information for HAdV-B7 and HAdV-B3 infected children
HAdV-B7 HAdV-B3
Variables Single infection Coinfection Single infection Coinfection
(n = 30) (n = 52) (n = 15) (n = 27)
Age (years)a 3.47 ± 3.08 1.20 ± 1.26 4.91 ± 4.63 2.62 ± 2.99
Male (%) 19 (63.3 %) 41 (56.2 %) 9 (60.0 %) 17 (63.0 %)
Symptoms and signs
Fever 29 (96.7 %) 51 (98.1 %) 15 (100 %) 24 (88.9 %)
T max (°C) 39.84 ± 0.71 39.50 ± 0.57 39.55 ± 0.53 39.78 ± 0.67
Duration of fever (days)b 22.07 ± 21.52 14.02 ± 6.36 9.73 ± 7.31 15.38 ± 14.36
Cough 30 (100 %) 52 (100 %) 15 (100 %) 26 (96.3 %)
Rhinorrhea 4 (13.3 %) 7 (13.5 %) 3 (20 %) 5 (18.5 %)
Wheezing 17 (56.7 %) 37 (71.2 %) 7 (46.7 %) 13 (48.1 %)
Swelling of tonsils 11 (36.7 %) 9 (17.3 %) 7 (46.7 %) 9 (33.3 %)
Rash 3 (10.0 %) 5 (9.6 %) 0 3 (11.1 %)
Vomitting 3 (10.0 %) 5 (9.6 %) 2 (13.3 %) 3 (11.1 %)
Diarrhea 9 (30.0 %) 13 (25.0 %) 1 (6.7 %) 7 (25.9 %)
Conjunctivitis 1 (3.3 %) 3 (5.8 %) 0 1 (3.7 %)
Dyspnea 13 (43.3 %) 26 (50.0 %) 4 (26.7 %) 9 (33.3 %)
ICU admission 6 (20.0 %) 7 (13.5 %) 0 2 (7.4 %)
Any underlying diseases 5 (16.7 %) 6 (11.5 %) 4 (26.7 %) 4 (14.8 %)
Treatment
Mechanical ventilation 8 (26.7 %) 19 (36.5%) 4 (26.7 %) 4 (14.8 %)
Coticosteriods 26 (86.7 %) 45 (86.5%) 12 (80.0 %) 24 (88.9 %)
Inhaled 16 (53.3 %) 29 (55.8%) 5 (33.3 %) 14 (51.9 %)
Intravenous
Immunoglobulinc 8 (26.7 %) 20 (38.5 %) 0 4 (14.8 %)
Length of hospital stay (days) 18.50 ± 12.87 22.44 ± 11.67 12.33 ± 4.95 16.89 ± 10.88
Laboratory findings
WBC (×109/L) 8.75 ± 4.63 9.96 ± 4.95 10.34 ± 5.23 10.87 ± 3.91
CRP (mg/L) 34.68 ± 42.70 33.95 ± 39.30 41.96 ± 36.84 31.54 ± 27.96
AST, median (IQR) (U/L)d 67 (38.8–100) 60 (38.3–94.3) 33 (27–45) 38 (26–51)
ALT, median (IQR) (U/L)e 20 (16–36) 25 (19–42.8) 15 (12–21) 17 (13–26)
LDH, median (IQR) (U/L)f 565 (341.8–1232.8) 470.5 (305.3–922.8) 297 (207–397) 311 (245–462)
CK, median (IQR) (U/L) 125.5 (48–499.8) 87 (45.5–187.5) 77 (46–99) 6 (43–115)
HBDH, median (IQR) (U/L)g 408 (242.8–803) 356.5 (225.9–647.5) 219 (162–313) 210 (199–374)
ICU intensive care unit, WBC white blood cell, CRP C-reaction protein, AST aspartate aminotransferase, ALT alanine aminotransferase, LDH lactate dehydrogenase,
CK creatinine kinase, HBDH hydroxybutyrate dehydrogenase, IQR interquartile range
aIndependent-Samples T test: HAdV-B7 single infection vs HAdV-B7 coinfection, p = 0.001
bIndependent-Samples T test: HAdV-B7 single infection vs HAdV-B3 single infection, p = 0.038
cFisher exact test: HAdV-B7 single infection vs HAdV-B3 single infecion, p = 0.038
dMann–Whitney U test: HAdV-B7 single infection vs HAdV-B3 single infection, p < 0.001
eMann–Whitney U test: HAdV-B7 single infection vs HAdV-B3 single infection, p = 0.029
fMann–Whitney U test: HAdV-B7 single infection vs HAdV-B3 single infection, p = 0.001
gMann–Whitney U test: HAdV-B7 single infection vs HAdV-B3 single infection, p = 0.001
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require care in an emergency department or hospital in
this age group.
Over a period of 6 years, 11 different types of HAdV
belonging to 4 species (HAdV-A, B, C, E) were identified
in respiratory specimens from children with ALRTIs.
HAdV-7 and HAdV-3 of species B comprised the most
prevalent types and presented throughout the duration
of the study. Although these results were consistent with
previous reports from Korea and Argentina [22, 28, 29],
investigations from Croatia, Peru, Canada, France
showed that species C predominated [1, 25, 26, 30]. This
difference in type prevalence may be attributed to differ-
ence in regions, year of study, and population recruited.
Notably, some newly emerging or re-emergent types
or variants were here identified, although only in rare
cases. Five patients were found to have HAdV-B55
(formerly named HAdV-11a), which is an uncommon
re-emergent type that once caused an outbreak of
respiratory tract infection in a senior high school in
Shanxi Province, China in 2006, including one fatal case
[15]. Subsequently, HAdV-B55 has been associated with
several outbreaks of respiratory disease in other prov-
inces in China [31]. An emerging variant, HAdV-B14p1
(formerly known as 14a), was also found. Recently,
HAdV-B14p1 has been associated with several large out-
breaks of acute respiratory infection, which included
severe and even fatal cases in the United States and
Europe [16, 32]. Additionally, in 2011, an outbreak of
febrile respiratory illness that affected 43 students in
Gansu Province, China was reported to be caused by
HAdV-B14p1 [33]. One HAdV-B14 infected patient who
presented with bronchopneumonia and required
hospitalization in April 2010 was identified. By further
sequencing the fiber gene (data not shown), this strain
was confirmed to be HAdV-B14p1 because it contained a
unique characteristic 6-nuleotid deletion in fiber knob
region as reported by Kajon et al. [32]. Last, this is the first
report of detection of HAdV-C57 in respiratory samples
collected from pediatric patients with ALRTIs and the first
of co-detection of HAdV-C57 with HAdVC-2. HAdV-C57
(formerly designated strain 16700) was first isolated from
the feces of a healthy child as part of an acute flaccid par-
alysis surveillance program. Computational genomic and
bioinformatic analysis showed HAdV-C57 to be a recom-
binant virus with fiber gene nearly identical to HAdV-C6
and a unique hexon distinct from all viruses in species
HAdV-C [34, 35]. Out of the three HAdV-C57-infected
cases identified here, one was a previously healthy 9-
month-old male who presented with bronchopneumonia
and conjunctivitis requiring hospitalization. Because only
a small number of HAdV-C57 positive cases were found
here and all were co-infected with other respiratory vi-
ruses, the pathogenic role of HAdV-C57 in respiratory in-
fections will require further investigation.
HAdV type is traditionally determined by virus isolation
and subsequently serum neutralization tests, in which
antibodies raised against specific type are used to suppress
cytopathic effects in tissue culture assays. By nature of its
design, this test can only reveal the dominant type. By ap-
plying PCR-based identification targeting hexon or fiber
genes, co-infections with multiple HAdV types (types
from same or different species) have been reported in both
immunocompromised and immunocompetent patients
[28, 29, 36–38]. In current study, results showed that one
specimen contained both HAdV-C2 and HAdV-C57 by
cloned sequencing the PCR products. These were ampli-
fied directly from respiratory samples using universal
primers of hexon gene. This co-infected phenomenon was
confirmed using the fiber gene sequencing results with
type-specific primers (data not shown). The specimen was
collected from a previously healthy 2.7-year old boy, pre-
senting with fever, coughing and seizure at emergency
department on December 10, 2009. Co-infection of differ-
ent HAdV types has never been reported in any previous
studies of Mainland China. The clinical implications of
such co-infection remain unclear, and its role in HAdV
pathogenesis and evolution will require further study.
Consistent with the report from Guangzhou, Southern
China [24], results here showed that 69.6% of HAdV-
infected participants were co-infected with one or more
other respiratory tract viruses and that RSV was the
most frequently co-detected virus. However, no signifi-
cant differences in clinical characteristics and laboratory
findings were found between patients with single HAdV
infection and those co-infected with RSV except that co-
infections were more frequently observed in younger
children. Similarly, a study from Peru also did found no
higher prevalence of any clinical manifestations in co-
infected patients than in those infected with HAdV
alone [26]. The results of another report from Chile
showed the clinical severity to be the same in patients
with single HAdV infection and those with mixed RSV-
HAdV infections [39]. These data demonstrate that, as
more sensitive molecular methods become more fre-
quently used to identify pathogens, co-detection of dif-
ferent viruses in the same specimen may also become
more common. However, the clinical role of such co-
infections will still require independent investigations.
Both HAdV-B7 and HAdV-B3 may cause severe or
even fatal pneumonia in even immunocompetent chil-
dren. Several previous studies showed that patients in-
fected with HAdV-B7 tend to have higher case-fatality
rates than those with HAdV-B3 [40, 41]. Two fatal cases
were recorded during the study period, and both of
these patients were infected with HAdV-B7 alone. Ana-
lysis revealed that patients with HAdV-B7 infection had
longer duration of fever and higher serum levels of
muscle enzymes than HAdV-B3-infected patients.
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Patients with HAdV-B7 infection also tended to require
longer hospital stays although no significant difference
was found. These differences have excluded the possible
interference by any other co-infected respiratory viruses
since this work only evaluated the patients with HAdV
infection alone. Such results may suggest that HAdV-B7
infection tended to cause more extrapulmonary tissue
damage (such as liver and heart) and may have more
severe clinical consequence.
This is a cross-sectional study. Only one respiratory
sample was collected from each patient and no viral load
analysis was performed. Although HAdV is a pathogen
that for long has been known to cause respiratory tract
infection, asymptomatic carriage of the virus may persist
for weeks [18]. The detection of HAdV in nasopharyn-
geal aspirate or throat swab with the use of a PCR assay
could represent convalescent-phase shedding, so detec-
tion may not suggest the current infection.
Conclusions
In summary, a total of 11 different types of HAdV were
identified in children with ALRTIs and HAdV-B7 and
HAdV-B3 were the most predominant types. Clinical
entities of patients with single HAdV infection were
similar to those with mixed HAdV/RSV infections.
HAdV-B7 infection tends to have more severe clinical
consequences. The presence of newly emerging types or
variants and co-infection with different types of HAdV
highlights the need for constant and close surveillance
of adenovirus infection.
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